John Pena

CEO, Board Member, QDTI Co-founder

John has over 2 decades of experience co-founding and building hard technology-based companies leading from inception to exit. He holds an economics degree from Duke University and Immunology Ph.D. from the University of Chicago. He is a former Investment associate of ARCH Venture partners (Hard tech industries); Founder and CEO of Ancora Pharmaceuticals which was acquired by Corden Pharma in 2012. John raised over $75MM as co-founder, executive and board member.


We use cookies to recognize your repeat visits and preferences, analyze traffic on our site, and provide a better user experience. By using our site, you agree to the use of cookies to collect information. Please visit our Privacy Policy for more information and to understand how we use your data.